Quotable: Top Experts On Policy Hot Topics

“The goal now is that for every ICER review, we are going to consistently evaluate the clinical trial diversity and give a rating of either good, fair or poor on clinical trial diversity.” – Foluso Agboola of the Institute for Clinical and Economic Review in the US. Find out more: ICER Debuts Clinical Trial Diversity Assessment Framework

“We're trying to come up with any solutions that we think could make 2025 smoother, but it's reasonable to expect that it's going to be painful. Taking the longer term...